GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Veeva Systems Inc.
Veeva Systems is a digital backbone for the pharmaceutical industry, providing cloud-based solutions for everything from research to sales. Its stock represents a bet on deep integration into a complex, regulated sector where digital transformation is only accelerating.
Share prices of companies in the market segment - It med
Veeva is a leader in cloud-based software for the pharmaceutical industry, supporting clinical trials and sales. We classify it as part of the IT medical sector, and the chart below reflects the dynamics of this segment, driven by rising R&D spending in the pharmaceutical industry.
Broad Market Index - GURU.Markets
Veeva Systems is a leading provider of cloud software for the global pharmaceutical and biotech industries. Its dominant role in this niche earns it a spot in the GURU.Markets index. The chart below represents the market. Is Veeva outperforming the overall IT sector?
Change in the price of a company, segment, and market as a whole per day
VEEV - Daily change in the company's share price Veeva Systems Inc.
Veeva Systems provides cloud-based software for the pharmaceutical and life sciences industries. Its daily price change is a measure of volatility in the medical technology sector. This metric is important for analytical formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - It med
Veeva Systems Inc. is a leader in cloud software for the pharmaceutical industry. This chart shows the average daily volatility of the sector. Comparing this to VEEV's performance helps us understand how its dominant position in its niche makes it more stable and predictable than other IT companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Veeva Systems provides cloud-based software for the pharmaceutical and life sciences industries. Its business is closely tied to healthcare and innovation in the healthcare sector. The chart below illustrates overall market volatility, which can be used to assess the stability and growth of this niche IT leader.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Veeva Systems Inc.
Veeva is the dominant cloud platform for the pharmaceutical industry. Its year-over-year growth reflects the deep penetration of its products into pharmaceutical companies' R&D and sales processes. The chart below tells the story of its indispensable role in this conservative yet technologically evolving sector.
Annual dynamics of market capitalization of the market segment - It med
Veeva Systems Inc. provides cloud-based software exclusively for the pharmaceutical and biotech industries. Deep specialization and dominance in its niche create a high barrier to entry for competitors. The chart below shows how this unique position allows it to grow faster than the broader IT sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Veeva Systems is a leading provider of cloud-based software for the pharmaceutical and life sciences industries. Its products are deeply integrated into customer R&D and sales processes, ensuring high customer loyalty and predictable revenue. Veeva's performance reflects the steady growth of the healthcare sector, rather than general economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Veeva Systems Inc.
Veeva Systems Inc.'s (VEEV) Perf_Month_Co market capitalization demonstrates sensitivity to the IT spending cycles of pharmaceutical and biotech companies. Medium-term fluctuations in the chart reflect market confidence in the sustainability of its cloud platform, the pace of new customer acquisition, and continued dominance in the life sciences IT niche.
Monthly dynamics of market capitalization of the market segment - It med
This chart illustrates the dynamics of the life sciences cloud software sector, where Veeva is the dominant player. Its steady growth reflects continued demand from pharmaceutical companies for its specialized CRM and regulatory solutions.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Veeva Systems provides cloud-based software for the global pharmaceutical and biotech industries. Its clients are established companies that rely on software for R&D and sales. The broader market chart shows how the indispensability of Veeva's products to its niche has made its shares more resilient to overall market fluctuations than those of other IT companies.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Veeva Systems Inc.
The weekly performance of Veeva Systems, a provider of cloud-based software for the pharmaceutical industry, is a barometer of digitalization in the life sciences. Its stock price reflects biotech and pharmaceutical companies' R&D spending, new product launches, and regulatory requirements that drive the adoption of specialized software.
Weekly dynamics of market capitalization of the market segment - It med
The cloud software sector for life sciences reflects the digitalization of the pharmaceutical industry. Weekly performance of the entire industry is driven by R&D spending and regulatory requirements. This chart illustrates this overall trend, which underscores Veeva's dominant position.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Veeva Systems provides cloud-based software for the pharmaceutical and biotech industries. Its clients are established companies, ensuring revenue predictability. This chart will help us understand whether long-term contracts in the pharmaceutical industry make Veeva's shares less volatile than the overall market, or whether its status as an IT company makes it more reactive to overall sentiment.
Market capitalization of the company, segment and market as a whole
VEEV - Market capitalization of the company Veeva Systems Inc.
Veeva Systems' market capitalization tells the story of its creation as a dominant cloud platform for the global pharmaceutical industry. The chart reflects how its specialized clinical trials and sales software has become an industry standard. Its robust growth reflects the market's appreciation of its deep integration into customer processes and the high cost of switching to competitors.
VEEV - Share of the company's market capitalization Veeva Systems Inc. within the market segment - It med
Veeva Systems is the dominant provider of cloud-based software for the global pharmaceutical and biotech industries. Its massive market share reflects a deep understanding of the industry's specific needs. The chart illustrates the weight of this niche technology company, which has become an indispensable partner for Big Pharma.
Market capitalization of the market segment - It med
Veeva Systems is the dominant provider of cloud software for the global pharmaceutical and biotech industries. The chart below shows the market capitalization of the medical IT sector. Its growth reflects the digitalization of R&D and sales in one of the most complex and regulated industries.
Market capitalization of all companies included in a broad market index - GURU.Markets
Veeva Systems is a cloud giant for the pharmaceutical and life sciences industries. Its market capitalization is a reflection of the complexity and overregulation of the healthcare industry. Veeva's growth, when viewed on the larger chart, demonstrates how specialized software is becoming critical infrastructure for entire sectors of the economy.
Book value capitalization of the company, segment and market as a whole
VEEV - Book value capitalization of the company Veeva Systems Inc.
Veeva Systems' book value is derived from its robust cloud infrastructure and capital, which supports the development of specialized software for the pharmaceutical industry. This is the tangible, technological foundation upon which clinical trials and drug sales are built. How has this unique asset grown? The chart below illustrates its steady progress.
VEEV - Share of the company's book capitalization Veeva Systems Inc. within the market segment - It med
Veeva Systems provides cloud solutions for the pharmaceutical industry, which requires highly reliable and secure data centers. The graph reflects the share of these physical assets in the IT sector, demonstrating the physical scale of the infrastructure required to store critical medical data.
Market segment balance sheet capitalization - It med
Providing cloud software for the pharmaceutical industry, like Veeva, is an asset-light business. Compared to the IT sector's assets, its subscription-based and intellectual property-based model allows it to be highly profitable without the need to own large physical assets.
Book value of all companies included in the broad market index - GURU.Markets
Veeva Systems' assets are secure data centers that run its specialized cloud-based software for the pharmaceutical industry. The book value reflects the physical infrastructure, which has become the industry standard for managing clinical trials and sales. The chart shows the weight of this IT platform.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Veeva Systems Inc.
Veeva Systems, a cloud-based software provider for the pharmaceutical industry, is valued dozens of times its tangible assets. Investors are paying a hefty premium for its dominant position in its niche, its strong customer base, and its stable subscription revenue.
Market to book capitalization ratio in a market segment - It med
Veeva Systems provides cloud solutions for the pharmaceutical and biotech industries. It's a highly specialized business with deep expertise. The chart shows that the market is willing to pay a significant premium for its dominant position in its niche and its subscription model with strong customer loyalty.
Market to book capitalization ratio for the market as a whole
Veeva Systems is the dominant provider of cloud-based software for the global pharmaceutical and biotech industries. The company has set the industry standard. Its intangible assets (code, reputation) are far more valuable than their physical assets. This metric demonstrates the high valuation of a company that has become an indispensable technology partner for an entire industry.
Debts of the company, segment and market as a whole
VEEV - Company debts Veeva Systems Inc.
Veeva Systems, a cloud-based software provider for the pharmaceutical industry, has a dominant position in its niche market. The company boasts high profitability and generates significant cash flow, allowing it to grow without taking on debt. This chart demonstrates its financial self-sufficiency and the strength of its subscription-based business model.
Market segment debts - It med
Veeva Systems is a provider of cloud-based software for the pharmaceutical and life sciences industries. The company holds a dominant position in its niche. Like many SaaS companies, Veeva may use debt for strategic acquisitions. This chart shows how conservative or aggressive its financial policy is compared to other cloud players.
Market debt in general
Veeva Systems is a provider of cloud-based software solutions for the global pharmaceutical and biotechnology industries. The company operates in a highly specialized and rapidly growing niche. This chart provides an opportunity to assess how conservative Veeva's financial policy, which funds its growth primarily through operating profit, is compared to the overall debt profile of the market.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Veeva Systems Inc.
Veeva Systems, a provider of cloud solutions for the pharmaceutical industry, has a strong market position and stable revenue. This chart shows its financial structure. Low debt is expected for such a profitable SaaS company and indicates its ability to fund growth and innovation internally.
Market segment debt to market segment book capitalization - It med
Veeva Systems, a provider of cloud software for the global pharmaceutical and biotech industries. This chart compares the company's debt to the overall market capitalization of the entire sector. It shows how this niche leader finances its dominance in a vertical market and how its financial strategy differs from that of broader enterprise software providers.
Debt to book value of all companies in the market
Veeva Systems, a provider of cloud-based software for the pharmaceutical industry, operates in a fast-growing, secure market. This chart compares the company's debt to the overall market capitalization. It helps understand how stable and unaffected by economic cycles this niche technology leader's financial policies are.
P/E of the company, segment and market as a whole
P/E - Veeva Systems Inc.
Veeva Systems provides cloud-based software for the pharmaceutical and biotech industries. This chart shows the premium investors are willing to pay for its dominant position in this vertical. This valuation reflects the indispensability of its products for clinical trials and drug sales.
P/E of the market segment - It med
Veeva Systems is a leader in cloud software for the global pharmaceutical and biotech industries. Its products help manage clinical trials, sales, and regulatory compliance. This chart shows the average valuation for the medical IT sector, allowing one to appreciate Veeva's premium value in its niche.
P/E of the market as a whole
Veeva Systems is the dominant cloud software provider for the global pharmaceutical industry. Its products are deeply integrated into R&D and sales processes. Does its high valuation reflect the general trend toward cloud technologies, or is it a unique bet on the indispensability of its platform in one of the world's richest and most stable industries?
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Veeva Systems Inc.
Veeva Systems provides cloud-based software specifically for the pharmaceutical and biotech industries. The company's future profitability is driven by R&D and sales expenditures in this industry. This chart reflects market expectations for the growth and digitalization of the global life sciences sector.
%20P%2FE%20Veeva%20Systems%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Veeva-Systems-Inc.&v=1772568648666 "Chart of the company's future (projected) P/E Veeva Systems Inc.")
Future (projected) P/E of the market segment - It med
Veeva Systems provides cloud-based software specifically designed for the pharmaceutical and life sciences industries, helping them manage clinical trials and sales. This chart compares Veeva's future revenue forecasts with software sector expectations, reflecting how highly the market values its dominant position in this vertical.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-It-med&v=1772568648717 "Future (projected) P/E graph of the market segment - It med")
Future (projected) P/E of the market as a whole
Veeva Systems provides cloud-based software to the global pharmaceutical and life sciences industries. Their niche dominance ensures stable growth. This overall expectations chart allows you to assess how the company, with its predictable business model, compares to overall market dynamics.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772568648895 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Veeva Systems Inc.
Veeva Systems provides cloud-based software for the pharmaceutical and biotech industries. This chart reflects its dominant position in this vertical niche. Steady revenue growth is driven by the deep integration of its products into clinical research and sales processes, creating high barriers to entry for competitors.
Profit of companies in the market segment - It med
Veeva Systems provides cloud-based software specifically designed for the pharmaceutical and biotech industries. This chart shows revenue in the medical IT sector. Veeva's deep industry expertise and dominant market position make it an indispensable partner for pharmaceutical companies, ensuring sustainable growth.
Overall market profit
Veeva Systems provides cloud-based software for the global pharmaceutical and biotech industries. Its products assist with clinical trials, marketing, and regulatory compliance. Demand for its services is very stable, as the pharmaceutical industry is less cyclical. However, the overall economic situation, reflected in the chart, influences risk appetite and R&D investment.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Veeva Systems Inc.
Veeva Systems Inc. is the dominant provider of cloud-based software for the global pharmaceutical and biotech industries. This chart reflects analyst expectations for future revenue. This forecast is supported by stringent regulatory requirements in the pharmaceutical industry, making Veeva's clinical trial data management products indispensable.
%20profit%20of%20the%20company%20Veeva%20Systems%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Veeva-Systems-Inc.&v=1772568649188 "Graph of future (projected) profit of the company Veeva Systems Inc.")
Future (predicted) profit of companies in the market segment - It med
Veeva Systems provides cloud-based software specifically designed for the pharmaceutical and biotech industries. The sector revenue forecasts shown here reflect general IT trends. This chart helps understand how Veeva's deep industry specialization enables it to create indispensable products for a highly regulated market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-It-med&v=1772568649292 "Graph of future (predicted) profits of companies in a market segment - It med")
Future (predicted) profit of the market as a whole
Veeva Systems provides cloud-based software for the global pharmaceutical and biotech industries. Its solutions help manage clinical trials and sales. R&D spending in this industry is less cyclical, but the overall health of the economy, reflected in the chart, creates a favorable backdrop for investment in innovation.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772568649347 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Veeva Systems Inc.
Veeva Systems provides cloud-based software specifically for the pharmaceutical and biotech industries. This chart shows the market premium the market is willing to pay for Veeva's revenue. The high premium reflects their dominant position in the vertical, regulatory barriers to entry, and stable growth thanks to deep customer integration.
P/S market segment - It med
Veeva Systems provides cloud-based software specifically designed for the pharmaceutical and biotech industries. Its products help manage clinical trials, sales, and regulatory compliance. This chart shows the average market value for the sector, helping to understand the market premium placed on Veeva's dominance in this vertical.
P/S of the market as a whole
Veeva Systems is a cloud-based software provider for the global pharmaceutical and biotech industries. Its products help manage clinical trials, sales, and regulatory compliance. The graph below compares the market's revenue estimates for this niche SaaS leader with overall revenue estimates across all industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Veeva Systems Inc.
Veeva Systems provides cloud-based software for the pharmaceutical and biotech industries. This chart reflects investors' very high valuation of its future subscription revenue. It demonstrates the market's confidence that Veeva will remain an indispensable technology partner for the life sciences industry, from research to sales.
%20P%2FS%20Veeva%20Systems%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Veeva-Systems-Inc.&v=1772568649520 "The graph of the company's future (projected) P/S Veeva Systems Inc.")
Future (projected) P/S of the market segment - It med
Veeva Systems provides cloud-based software designed specifically for the pharmaceutical and life sciences industries. This chart compares the company's estimated future sales with other healthcare IT companies. It reflects investor confidence that stringent regulatory requirements and digitalization in the pharmaceutical industry will continue to support demand for its niche products.
%20P%2FS%20market%20segment%20graph%20-%20It%20med&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-It-med&v=1772568649611 "Future (projected) P/S market segment graph - It med")
Future (projected) P/S of the market as a whole
Veeva Systems provides cloud-based software for the pharmaceutical and biotech industries. Its products help manage clinical trials, sales, and regulatory compliance. This graph of overall market expectations is less important to Veeva than the dynamics of R&D spending in the pharmaceutical industry, which is its key growth driver.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772568649616 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Veeva Systems Inc.
This chart shows the revenue of Veeva Systems, a provider of cloud-based software for the pharmaceutical and biotech industries. Revenue is generated from subscriptions to its specialized CRM systems and clinical trial management solutions. This growth reflects the digitalization of the pharmaceutical industry and Veeva's unique niche position as an industry standard.
Sales of companies in the market segment - It med
Veeva Systems is a cloud-based software provider for the global pharmaceutical and biotech industries. Its products help manage clinical trials, sales, and regulatory compliance. This chart shows revenue in the healthcare IT sector. It reflects the digitalization of the pharmaceutical industry, which is driving high demand for Veeva's specialized and regulatory-compliant solutions.
Overall market sales
Veeva Systems provides cloud-based software specifically for the pharmaceutical and biotech industries. Its platforms help manage clinical trials, sales, and regulatory compliance. The company's growth depends on investment in pharmaceutical R&D, which is stable, but the overall economic recovery, reflected in the graph, is accelerating the adoption of new technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Veeva Systems Inc.
Veeva Systems provides cloud-based software for the global pharmaceutical and biotech industries. This revenue forecast chart reflects IT spending in this sector. This increase reflects expectations of increased demand from pharmaceutical companies for specialized solutions for clinical trials, data management, and physician engagement.
%20sales%20of%20the%20company%20Veeva%20Systems%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Veeva-Systems-Inc.&v=1772568649896 "Schedule of future (projected) sales of the company Veeva Systems Inc.")
Future (projected) sales of companies in the market segment - It med
Veeva Systems is a provider of cloud-based software designed specifically for the pharmaceutical and biotech industries. Their solutions help manage clinical trials, sales, and regulatory compliance. This chart shows projected revenue for the medical IT sector, reflecting digitalization trends in one of the most regulated industries in the world.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-It-med&v=1772568649953 "Schedule of future (projected) sales of companies in the market segment - It med")
Future (projected) sales of the market as a whole
Veeva Systems provides cloud-based software for the pharmaceutical and biotechnology industries. Its success depends on investment in research and development (R&D) in this area. Stable economic growth, reflected in overall forecasts, ensures sustainable R&D funding, leading to increased demand for Veeva's specialized solutions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772568649985 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Veeva Systems Inc.
Veeva Systems provides cloud-based software specifically designed for the pharmaceutical and biotech industries. This chart demonstrates the high profitability of its dominant position in its niche. Deep integration into customer processes and low switching costs ensure Veeva's stable revenue and impressive efficiency.
Market segment marginality - It med
Veeva Systems is a provider of cloud-based software for the global pharmaceutical and life sciences industries. Its success depends on the profitability of its specialized CRM and R&D solutions. This chart shows the average profitability in the software sector. It helps us understand how Veeva's deep penetration into its industry niche gives it a competitive advantage.
Market marginality as a whole
Veeva Systems is a leading provider of cloud-based software for the global pharmaceutical and life sciences industries. Its business is largely independent of general economic cycles, as reflected in this chart. Pharmaceutical companies are required to comply with strict regulatory requirements, making Veeva's software critical to their operations, ensuring stable subscription revenue.
Employees in the company, segment and market as a whole
Number of employees in the company Veeva Systems Inc.
Veeva Systems has created a cloud platform that has become the industry standard for pharmaceutical and biotech companies. Working in such a highly regulated industry requires deep expertise. This chart shows the growth of the team of specialists who help pharmaceutical giants manage clinical trials, sales, and regulatory compliance.
Share of the company's employees Veeva Systems Inc. within the market segment - It med
Veeva Systems is a company specializing in cloud computing for the life sciences industry. Its specialized software for pharmaceutical companies requires deep expertise in both technology and pharmaceuticals. This metric demonstrates its market dominance, measuring its share of highly specialized IT talent serving the life sciences sector.
Number of employees in the market segment - It med
Veeva Systems has created a cloud platform that has become the industry standard for pharmaceutical and biotech companies. It helps manage everything from clinical trials to sales. This graph shows how specialized software is conquering entire industries. The growth in employment reflects deep industry penetration and the successful expansion of its product suite.
Number of employees in the market as a whole
Veeva Systems provides cloud-based software for the pharmaceutical industry. The growth of its staff, comprised of highly specialized professionals, is a direct indicator of the health and level of R&D spending in the entire pharmaceutical industry.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Veeva Systems Inc. (VEEV)
Veeva Systems provides cloud-based software for the pharmaceutical industry. Their value lies in their dominance in their vertical. This is a very high-growth opportunity for them. They have created the industry standard, and their software is deeply integrated into their clients' processes. This allows them to scale effectively and generate high value per employee.
%20of%20the%20company%20Veeva%20Systems%20Inc.%20(VEEV)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Veeva-Systems-Inc.-VEEV&v=1772568650583 "Chart of market capitalization per employee (in thousands of dollars) of the company Veeva Systems Inc. (VEEV)")
Market capitalization per employee (in thousands of dollars) in the market segment - It med
Veeva Systems is a cloud software provider (SaaS) specifically for the pharmaceutical industry (CRM, data management). It's a niche, yet dominant and highly profitable business. Compared to the industry average, this figure should be very high, reflecting how much the market values their deep industry expertise and robust ecosystem per employee.
%20by%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-It-med&v=1772568650638 "Market capitalization per employee (in thousands of dollars) by market segment - It med")
Market capitalization per employee (in thousands of dollars) for the overall market
Veeva Systems provides cloud-based solutions for the pharmaceutical and biotech industries. This metric illustrates the strength of the vertical SaaS model. The company dominates its niche, offering indispensable products. This ensures stable growth, high margins, and, consequently, a very high market valuation per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772568650674 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Veeva Systems Inc. (VEEV)
Veeva Systems is a cloud-based (SaaS) platform designed specifically for the pharmaceutical industry. They help manage everything from R&D to sales and regulatory compliance. They're a niche, yet dominant player. This chart shows how in-demand their software is. Their high revenue per employee is a result of deep expertise and high subscription revenue.
%20Chart%20Veeva%20Systems%20Inc.%20(VEEV)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Veeva-Systems-Inc.-VEEV&v=1772568650720 "Company Profit Per Employee (in thousands of dollars) Chart Veeva Systems Inc. (VEEV)")
Profit per employee (in thousands of dollars) in the market segment - It med
Veeva Systems is a vertical SaaS solution for the pharmaceutical industry (CRM, data management). This chart shows the benchmark for "Medical IT." The average profit per employee here is astronomical. The sector provides "sticky," mission-critical, regulated software for which clients (pharmaceutical companies) pay huge sums.
%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-It-med&v=1772568650737 "Chart of profit per employee (in thousands of dollars) in the market segment - It med")
Profit per employee (in thousands of dollars) for the market as a whole
Veeva Systems is a leader in cloud-based software for the pharmaceutical and biotech industries. The company provides highly specialized solutions for clinical research and sales. This chart demonstrates how a niche SaaS business generates extremely high profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772568650782 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Veeva Systems Inc. (VEEV)
Veeva Systems provides cloud-based software for the pharmaceutical and biotech industries. This chart demonstrates the company's dominant position in its vertical. Their high revenue per employee reflects the deep integration of their products into customer processes and their highly loyal subscription model.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Veeva-Systems-Inc.-VEEV&v=1772568650838 "Sales chart per company employee Veeva Systems Inc. (VEEV)")
Sales per employee in the market segment - It med
Veeva Systems is the dominant provider of cloud software (CRM, data management) specifically for the pharmaceutical industry. It's a classic vertical SaaS business with high barriers to entry. This chart shows the industry's average revenue per employee. It helps assess how effectively Veeva is monetizing its niche with its R&D and S&M teams.
Sales per employee for the market as a whole
Veeva Systems is the dominant SaaS platform for the pharmaceutical industry. They provide cloud-based software for everything from R&D and clinical trials to sales management (CRM). This chart demonstrates the power of their vertical SaaS model: their development team creates a niche product that generates huge and stable revenue per employee in a thriving industry.
Short shares by company, segment and market as a whole
Shares shorted by company Veeva Systems Inc. (VEEV)
Veeva Systems is a dominant provider of cloud-based CRM software for the pharmaceutical and biotech industries. This chart shows bearish bets. Bearish bets indicate a very high valuation and risks associated with customer concentration (dependence on large pharmaceutical companies) or the emergence of new, cheaper competitors.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Veeva-Systems-Inc.-VEEV&v=1772568650939 "Short Shares Chart for the Company Veeva Systems Inc. (VEEV)")
Shares shorted by market segment - It med
Veeva Systems is the dominant provider of cloud-based software (CRM and data management) for the pharmaceutical and biotech industries. This chart shows bearish bets. "Shorting" Veeva is a bet on a slowdown in the biotech sector. If investors expect R&D budgets to shrink and clinical trials to decline, they "short" Veeva, whose revenue is directly dependent on these factors.
Shares shorted by the overall market
Veeva Systems is a dominant provider of cloud software for the conservative life sciences industry (pharma, biotechnology). This indicator of market pessimism is a test for Veeva. On the one hand, its customers (pharma companies) are a defensive sector. On the other, Veeva's high valuation makes it vulnerable to "risk-off" sentiment, when investors prefer to exit expensive growth stocks.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Veeva Systems Inc. (VEEV)
Veeva Systems provides cloud-based software specifically for the pharmaceutical industry. Its business depends on pharmaceutical companies' R&D budgets. This indicator, above 70, may reflect strong growth in the biotech sector. Oversold levels (<30) are often associated with concerns about slowing R&D or increased competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Veeva-Systems-Inc.-VEEV&v=1772568651137 "RSI 14 indicator chart for the company's stock Veeva Systems Inc. (VEEV)")
RSI 14 Market Segment - It med
Veeva (VEEV) is the "Salesforce" of the pharma industry. They provide cloud-based software that helps pharma companies manage everything from R&D to sales. This metric measures the "temperature" of the entire software sector. It helps us understand: is VEEV overheated due to its monopoly in the niche, or is the entire vertical software sector overbought?
RSI 14 for the overall market
Veeva Systems provides cloud-based software specifically designed for the pharmaceutical and life sciences industries, a highly specialized and rapidly growing sector. This chart shows the overall market temperature. It helps understand whether VEEV fluctuations are driven by general euphoria in the tech sector (overbought) or panic, rather than genuine demand from pharma.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast VEEV (Veeva Systems Inc.)
Veeva Systems is the dominant provider of cloud-based software for the pharmaceutical industry. Their software manages everything from clinical trials to physician relationship management (CRM). This chart represents the analysts' collective forecast. It shows the average target price, reflecting their bets on growing biotech R&D budgets and the implementation of new Veeva modules.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-VEEV-Veeva-Systems-Inc.&v=1772568651430 "A chart showing analyst consensus forecasts for the expected stock price. VEEV (Veeva Systems Inc.)")
The difference between the consensus estimate and the actual stock price VEEV (Veeva Systems Inc.)
Veeva Systems (VEEV) is the dominant provider of cloud software (CRM and data management) for the pharmaceutical and biotech industries. They help manage everything from R&D to sales. This chart shows the pharma cloud valuation. It demonstrates the gap between the price and the consensus target, reflecting the growth potential analysts see in their near-monopoly position.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-VEEV-Veeva-Systems-Inc.&v=1772568651513 "A chart showing the difference between the consensus forecast and the actual stock price. VEEV (Veeva Systems Inc.)")
Analyst consensus forecast for stock prices by market segment - It med
Veeva Systems is the dominant provider of cloud-based software (SaaS) for the pharmaceutical industry. Their software helps "big pharma" manage clinical trials and sales. This chart shows analysts' overall expectations for the healthcare software sector. It reflects whether experts believe R&D budgets in the pharmaceutical industry will grow.
Analysts' consensus forecast for the overall market share price
Veeva Systems provides cloud-based software specifically designed for the life sciences industry (pharmaceuticals, biotechnology). The company dominates its niche. This chart reflects aggregate expert expectations. For Veeva, whose business is tied to the stable pharmaceutical sector, general market pessimism may be less damaging than for other IT companies, a fact often appreciated by investors.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Veeva Systems Inc.
Veeva Systems is a dominant provider of cloud-based software (CRM and data management) designed specifically for the needs of the pharmaceutical industry. This chart is an indicator of the digitalization of big pharma. It reflects their deep penetration into the industry (high customer stickiness) and their ability to expand their product portfolio, covering everything from R&D to sales.
AKIMA Market Segment Index - It med
Veeva Systems – Salesforce for Pharmaceuticals. This SaaS company provides highly specialized cloud software that helps pharmaceutical companies manage everything from R&D to sales. This aggregate metric evaluates companies. The chart shows the average value for the software segment. This benchmark: how does Veeva's monopoly position in its vertical differentiate it from the average competitor?
The AKIM Index for the overall market
Veeva Systems is the dominant provider of cloud-based software for the pharmaceutical industry. Its systems help manage everything from R&D and clinical trials to sales and marketing (CRM). This chart, showing the market average, provides context. It helps us understand how Veeva, which serves the protective healthcare sector, fits into the overall macroeconomic picture that impacts pharmaceutical companies' IT budgets.
